Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Dose and Frequency Finding Study of MOD-4023 in Growth Hormone Deficient Adults (GHDA)

NCT01225666 is registered in ClinicalTrials.gov with OPKO Health, Inc. as lead sponsor.

NCT NCT01225666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01225666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Dose and Frequency Finding Study of MOD-4023 in Growth Hormone Deficient Adults (GHDA)
Lead sponsor
OPKO Health, Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2010
Completion date
April 30, 2012
Enrollment
52 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

adult growth hormone deficiency